Cipla, Alkem eye Rs 4,000 crore stake in India's largest stent manufacturer

Q: How long will it take to read this news story?

The story "Cipla, Alkem eye Rs 4,000 crore stake in India&#039;s largest stent manufacturer" has 402 words across 19 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Cipla, Alkem eye Rs 4,000 crore stake in India&#039;s largest stent manufacturer" was covered 9 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 339 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23084834</li><li>URL: https://beamstart.com/news/cipla-alkem-eye-rs-4000-17290691832313</li></ul>

Business Standard Logo Business Standard 9h ago

Cipla, Alkem eye Rs 4,000 crore stake in India's largest stent manufacturer - Business Standard

Quick Summary:

Indian manufacturers, including SMT, Translumina, and Meril Life Sciences, together control around 18-20 per cent of the market.BEML wins Rs 866.

The medical device company initially filed for a Rs 1,500 crore IPO with the Securities and Exchange Board of India (Sebi) in 2022 but paused those plans.

This comes after private equity giants KKR, TPG Capital, and Apax Partners withdrew from the race, having initially shown interest, reported The Economic Times citing sources.